Increasing yield of anti-malarial medicine through fast track plant breeding
The medicinal plant Artemisia annua is the primary source of the leading antimalarial, artemisinin. However the yield of the drug is very low making it expensive and unprofitable to produce.
Cheaper anti-malarial drugs for all
Our academic founder CNAP, increased the yield of artemisinin by applying a treatment that increases genetic diversity to A. annua seed. Using high-throughput genetic and phenotypic tests to select individual plants with increased levels of the drug, they developed genetic markers to fast-track breed high-yield hybrids.
The new varieties will be supplied for cultivation in Africa, India and China helping malarial nations contribute to their own national health issues.
Artemisia annua is the primary source of artemisinin
Increasing the yield of artemisinin makes it cheaper
Cultivation in Africa, India and China
Let's work together
We have worked on 1,500 bio-based projects to date
We have several ways to work with us, including business advisory programmes and self-funded commercial options. We even have the option for you to hire our state-of-the-art laboratory equipment and office space.
